Exelon (NASDAQ:EXC)‘s stock had its “outperform” rating restated by investment analysts at Credit Suisse Group in a report released on Tuesday, Benzinga reports.
EXC has been the subject of several other reports. Mizuho lowered their price objective on shares of Exelon from $37.00 to $36.00 and set an “underperform” rating for the company in a research note on Thursday, November 19th. Morgan Stanley dropped their price target on Exelon from $59.00 to $56.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 15th. Guggenheim cut Exelon from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $46.00 to $42.00 in a research note on Monday, October 26th. Argus upped their target price on Exelon from $42.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, December 11th. Finally, Bank of America raised shares of Exelon from a “neutral” rating to a “buy” rating in a research report on Wednesday, January 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the company’s stock. Exelon presently has a consensus rating of “Buy” and a consensus target price of $45.00.
NASDAQ:EXC opened at $40.60 on Tuesday. The company has a current ratio of 1.09, a quick ratio of 0.94 and a debt-to-equity ratio of 1.02. Exelon has a twelve month low of $29.28 and a twelve month high of $50.47. The company has a market cap of $39.61 billion, a PE ratio of 16.71, a P/E/G ratio of 5.31 and a beta of 0.41. The company’s 50 day moving average is $42.48 and its two-hundred day moving average is $42.04.
Exelon Corporation, a utility services holding company, engages in the generation and marketing of energy in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, biomass, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.
Read More: Marijuana Stocks
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.